You are here: Industry Insights > Johnson & Johnson

News List

J&J loses yet another fight to protect Zytiga from generics fiercepharma
November 27, 2018
Johnson & Johnson lost its latest effort to fend off Zytiga generics in court, sending investors reeling at the prospect of losing blockbuster sales. But the pharma giant says it’s now planning a last-ditch stand at the U.S. Supreme Court.
Johnson & Johnson backs new Invokana CV nod with series of awareness tweets fiercepharma
November 15, 2018
ohnson & Johnson’s new Invokana cardiovascular indication is getting a Twitter assist. J&J is using the social media platform to get the word out about the link between Type 2 diabetes and cardiovascular risks...
Outbreak alliance hands Johnson & Johnson, Oxford $18.7M for MERS work and more fiercepharma
November 09, 2018
CEPI, the global outbreak preparedness group, has been busy since it launched last year, raising more than $600 million and handing out grants to back research into
J&J touts latest immune response data for 'mosaic' HIV vaccine program fiercepharma
November 09, 2018
Johnson & Johnson has already advanced a “mosaic” HIV vaccine candidate into efficacy testing in five southern African countries, but this week the company unveiled initial
Johnson & Johnson drops OSE’s rheumatoid arthritis drug fiercebiotech
November 05, 2018
Johnson & Johnson has dumped OSE Immunotherapeutics’ autoimmune candidate FR104. J&J picked up the rights to the CD28 antagonist for...
Outbreak alliance hands Johnson & Johnson, Oxford $18.7M for MERS work and more fiercepharma
September 28, 2018
J&J and Oxford University snagged $18.7 million for work on MERS, Lassa and Nipah vaccines.
Roche, Johnson & Johnson pulled into Justice Department probe of alleged terrorist bribes fiercepharma
August 03, 2018
Days after AstraZeneca disclosed that it’s under Justice Department scrutiny for allegedly funding Iraqi terrorism, Johnson & Johnson and Roche also revealed similar inquiries from the agency.
Johnson & Johnson predicts 4% to 6% net price decline in pharma this year, with Remicade down by double digits in Q2 fiercepharma
July 18, 2018
With the pharmaceutical industry closely tracking pricing developments, Johnson & Johnson executives shared the drug giant's perspective after reporting second-quarter results Tuesday.
Johnson & Johnson scores third appeals win—this one for $55M—in talc powder litigation fiercepharma
July 04, 2018
Johnson & Johnson has scored again in its appeals campaign against talcum powder verdicts. After the company last year secured two major reversals, a Missouri appeals court has overturned another verdict worth $55 million.
Johnson & Johnson announces progress toward health for humanity goals financialexpress
June 14, 2018
Johnson & Johnson has recently released its 2017 Health for Humanity Report, demonstrating its approach and the considerable progress it has made toward an ambitious social, environmental and governance commitment to advance the Company’s mission to drive

Previous page 1 2 3 4 5 6 7 8 9 10 ... 15 16 Next page